As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

Compounded medications aren't FDA-approved, but the facilities in ... drugmakers and the FDA share concerns about fake or subpar weight loss drugs — even though regulated compounders often ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

Leigh-Anne Lagden, 26, opened up about being hospitalized after accidentally overdosing on knockoff weight loss injections ...

These include knockoffs of popular weight loss drugs. Customs officials allowed CBS News a rare ... patients are aware that Novo Nordisk is the only company in the U.S. with FDA-approved medicines ...

European Union antitrust regulators will decide by Dec. 6 whether to clear Novo Holdings’ acquisition of contract drug ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

Feb. 22, 2024 When the semaglutide medication Wegovy first hit the market in 2021, it became the first weight-loss drug to ...

US Food and Drug Administration (FDA) regulations allow human drug compounding — in which licensed pharmacists or physicians can combine, mix, or adjust the ingredients of a medication — to meet ...

Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including ...